Status:
RECRUITING
CIFeR - A Clinician-led Intervention to Address Fear of Cancer Recurrence
Lead Sponsor:
Aarhus University Hospital
Conditions:
Fear of Cancer Recurrence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will test a novel Clinician-led Intervention to address Fear of cancer Recurrence in cancer survivors (CIFeR), by 1) adapting the original Australian intervention manual to the Danis...
Detailed Description
STUDY DESIGN: The study is designed as a parallel cluster-randomized controlled trial with oncologists (cluster unit) treating breast, ovarian, and prostate cancer at the oncology departments at Aarh...
Eligibility Criteria
Inclusion
- Are ≥ 18 years old
- Have completed their primary treatment, i.e., surgery, adjuvant chemotherapy, and/or radiotherapy, for breast, ovarian, prostate, or lung cancer at the participating departments between three weeks and three months previously.
- Score \>= 13 on the FCRI-SF
Exclusion
- \-
Key Trial Info
Start Date :
June 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06554899
Start Date
June 14 2024
End Date
June 1 2026
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200